Strata Critical Medical (SRTA) Short-term Investments (2020 - 2026)

Strata Critical Medical (SRTA) has reported Short-term Investments for 7 consecutive years, with $66000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Short-term Investments fell 99.92% year-over-year to $66000.0; the TTM figure through Mar 2026 stood at $66000.0 (down 99.92% YoY), while the FY2025 annual figure was $30.3 million, down 72.17% from the prior year.
• Short-term Investments declined to $66000.0 in Q1 2026 per SRTA's latest filing, from $30.3 million in the prior quarter.
• Across five years, Short-term Investments topped out at $266.6 million in Q1 2022 and bottomed at $66000.0 in Q1 2026.
• Historically, Short-term Investments has averaged $109.3 million across 5 years, with a median of $115.6 million in 2024.
• Annual changes were most pronounced in 2022 — Short-term Investments soared 10948.73% — and 2026, when it sank 99.92%.
• Strata Critical Medical's Short-term Investments stood at $150.7 million in 2022, then dropped by 8.28% to $138.3 million in 2023, then fell by 21.34% to $108.8 million in 2024, then sank by 72.17% to $30.3 million in 2025, then slumped by 99.78% to $66000.0 in 2026.
• Business Quant data shows SRTA's Short-term Investments at $66000.0 in Q1 2026, $30.3 million in Q4 2025, and $53.2 million in Q3 2025.